2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Update on Adjuvant Therapy in BC: Is There a Long-term Benefit of MammaPrint as Guidance for Chemo? Does Trastuzumab + Pertuzumab + Chemotherapy Remain SoC for High-risk HER2+ EBC?

470 views
July 8, 2020
Comments 0
Login to view comments. Click here to Login